Catalyst Wire Dossier Catalyst Wire Dossier

Ciprofloxacin inhalation powder

ciprofloxacin · Bayer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ciprofloxacin inhalation powder, covering 2014-04-14 to 2014-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder [Phase 1]

See pricing